HeartBeam (NASDAQ: BEAT), a medical technology company developing personalized cardiac-care insights, detailed its ...

SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, today announced ...

The Future of Health in 2026: AI Breakthroughs, Personalized Medicine, and the New Era of Patient Care As we navigate ...

In August, all 11 hospitals within New York City-based NYC Health + Hospitals were recognized by the American Heart Association for providing quality cardiovascular and stroke care. Of those 11 ...

GE HealthCare GEHC recently unveiled new advancements in precision cardiac care at the 2025 SNMMI annual meeting in New Orleans, with a spotlight on Flyrcado—its FDA-approved Positron Emission ...

A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk for the most common type of heart attack more accurately than existing ...

Late-stage failure of the left side of the heart is an often-fatal condition affecting hundreds of thousands of people in the U.S. alone. A mechanical heart pump can be a lifesaving intervention for ...

Please provide your email address to receive an email when new articles are posted on . A randomized controlled trial will compare an AI-assisted strategy to stage coronary heart disease vs. usual ...